Nhảy đến nội dung

TS. Nguyễn Phương Trâm

Hồ sơ giảng viên Faculty Profile
TS. Nguyễn Phương Trâm

TS. Nguyễn Phương Trâm Nguyễn Phương Trâm

Học vị: Tiến sĩ

Chức danh chuyên môn: Giảng viên

Bộ môn: Khoa học y sinh và Dược lý

Chuyên môn: Nghiên cứu y học

Email: nguyenphuongtram@tdtu.edu.vn

Academic degree: Doctor

Academic title: Lecturer

Department: Department of Biomedical Science and Pharmacology

Specialization: Medical Studies

Email: nguyenphuongtram@tdtu.edu.vn

 

🔬 Hướng nghiên cứu chính 🔬 Main Research Directions

  • Đánh giá hoạt tính sinh học và tiềm năng của dược liệu, vật liệu sinh học, thuốc tổng hợp và lợi khuẩn.
  • Biological activities and potential applications of natural products, biomaterials, synthetic drugs and probiotics

🧑‍🏫 Các môn giảng dạy tiêu biểu 🧑‍🏫 Teaching Subjects

  • Hoá sinh
  • Anh văn chuyên ngành
  • Biochemistry
  • English in Pharmacy

🎓 Quá trình đào tạo 🎓 Education

  • 2020-2023: Tiến sĩ Nghiên cứu y học, Đại học Tasmania, Úc
  • 2016-2018: Thạc sĩ Dược học, Đại học Quốc Gia Kangwon, Hàn Quốc
  • 2011-2015: Cử nhân Công nghệ sinh học, Trường Đại học Quốc tế, Đại học Quốc Gia TP.HCM
  • 2020-2023: Doctor of Philosophy in Medical Studies, University of Tasmania, Australia
  • 2016-2018: Master of Science in Pharmacy, Kangwon National University, South Korea
  • 2011-2015: Bachelor of Science in Biotechnology, International U

🏢 Quá trình công tác 🏢 Professional Experience

  • 2024-nay: Giảng viên, Khoa Dược, Trường Đại học Tôn Đức Thắng
  • 2022-2023: Trợ lý nghiên cứu, Viện nghiên cứu Y học Menzies, Đại học Tasmania, Úc
  • 2024-present: Lecturer, Faculty of Pharmacy, Ton Duc Thang University
  • 2022-2023: Research Assistant, Menzies Institute for Medical Research, University of Tasmania, Australia

📑 Công bố khoa học 📑 Publications

    1. Nguyen PT*, Zarghami A*, Makowiecki K*, Stevens N, Ezegbe V, Kyle K, Wang CT, Ly L, De La Rue K, Hinder MR, Johnson L, Rodger J, Cooper S, Cullen CL, Barnett MH, Young KM, Taylor BV (2024). Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS-outcomes of the phase I randomised controlled trial (TAURUS). Multiple Sclerosis Journal – Experimental, Translational and Clinical. *Co-first authors
    2. Krishnamurthy G, Nguyen PT, Tran BN, Phan HT, Brennecke SP, Moses EK, Melton PE (2023). Genomic variation associated with cardiovascular disease progression following preeclampsia: A systematic review. Frontiers in Epidemiology. 3:1221222.
    3. Makowiecki K, Stevens N, Cullen CL, Zarghami A, Nguyen PT, Johnson L, Rodger J, Hinder MR, Barnett M, Young KM, Taylor BV (2021). Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial. Trials. 23: 626.
    4. Nguyen PT*, Dang DK*, Tran HQ, Shin EJ, Jeong JH, Nah SY, Cho MC, Lee YS, Jang CG, Kim HC (2019). Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors. Chemico-Biological Interactions. 305: 134-147. *Co-first authors
    5. Mai HN, Sharma N, Shin EJ, Nguyen BT, Nguyen PT, Jeong JH, Cho EH, Lee YJ, Kim NH, Jang CG, Nabeshima T, Kim HC (2018). Exposure to far-infrared rays attenuates methamphetamine-induced impairment in recognition memory through inhibition of protein kinase Cδ in male mice: Comparison with the antipsychotic clozapine. Journal of Neuroscience Research. 96(7): 1294-1310.
    6. Mai HN, Sharma N, Shin EJ, Nguyen BT, Nguyen PT, Jeong JH, Jang CG, Cho EH, Nah SY, Kim NH, Nabeshima T, Kim HC (2018). Exposure to far-infrared rays attenuates methamphetamine-induced recognition memory impairment via modulation of the muscarinic M1 receptor, Nrf2 and PKC. Neurochemistry International. 116: 63-76.
    7. Nguyen PT*, Shin EJ*, Dang DK, Tran HQ, Jang CG, Jeong JH, Lee YJ, Lee HJ, Lee YS, Yamada K, Nabeshima T, Kim HC (2018). Role of dopamine D1 receptors in 3-fluoromethamphetamine-induced neurotoxicity in mice. Neurochemistry International. 113:69-84. *Co-first authors
    8. Shin EJ, Tran HQ, Nguyen PT, Jeong JH, Nah SY, Jang CG, Nabeshima T, Kim HC (2018). Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: Involvement in oxidative stress, neuroinflammation, and pro-apoptosis – A review. Neurochemical Research. 43(1): 66-78.
    1. Nguyen PT*, Zarghami A*, Makowiecki K*, Stevens N, Ezegbe V, Kyle K, Wang CT, Ly L, De La Rue K, Hinder MR, Johnson L, Rodger J, Cooper S, Cullen CL, Barnett MH, Young KM, Taylor BV (2024). Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS-outcomes of the phase I randomised controlled trial (TAURUS). Multiple Sclerosis Journal – Experimental, Translational and Clinical. *Co-first authors
    2. Krishnamurthy G, Nguyen PT, Tran BN, Phan HT, Brennecke SP, Moses EK, Melton PE (2023). Genomic variation associated with cardiovascular disease progression following preeclampsia: A systematic review. Frontiers in Epidemiology. 3:1221222.
    3. Makowiecki K, Stevens N, Cullen CL, Zarghami A, Nguyen PT, Johnson L, Rodger J, Hinder MR, Barnett M, Young KM, Taylor BV (2021). Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial. Trials. 23: 626.
    4. Nguyen PT*, Dang DK*, Tran HQ, Shin EJ, Jeong JH, Nah SY, Cho MC, Lee YS, Jang CG, Kim HC (2019). Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors. Chemico-Biological Interactions. 305: 134-147. *Co-first authors
    5. Mai HN, Sharma N, Shin EJ, Nguyen BT, Nguyen PT, Jeong JH, Cho EH, Lee YJ, Kim NH, Jang CG, Nabeshima T, Kim HC (2018). Exposure to far-infrared rays attenuates methamphetamine-induced impairment in recognition memory through inhibition of protein kinase Cδ in male mice: Comparison with the antipsychotic clozapine. Journal of Neuroscience Research. 96(7): 1294-1310.
    6. Mai HN, Sharma N, Shin EJ, Nguyen BT, Nguyen PT, Jeong JH, Jang CG, Cho EH, Nah SY, Kim NH, Nabeshima T, Kim HC (2018). Exposure to far-infrared rays attenuates methamphetamine-induced recognition memory impairment via modulation of the muscarinic M1 receptor, Nrf2 and PKC. Neurochemistry International. 116: 63-76.
    7. Nguyen PT*, Shin EJ*, Dang DK, Tran HQ, Jang CG, Jeong JH, Lee YJ, Lee HJ, Lee YS, Yamada K, Nabeshima T, Kim HC (2018). Role of dopamine D1 receptors in 3-fluoromethamphetamine-induced neurotoxicity in mice. Neurochemistry International. 113:69-84. *Co-first authors
    8. Shin EJ, Tran HQ, Nguyen PT, Jeong JH, Nah SY, Jang CG, Nabeshima T, Kim HC (2018). Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: Involvement in oxidative stress, neuroinflammation, and pro-apoptosis – A review. Neurochemical Research. 43(1): 66-78.